Biotech Sector ETFs Could See Big Day on GILD/VRUS Deal
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- Nasdaq ends down as chipmakers fall and bank earnings roll in
- Oil prices settle mixed, focus on US-Russia diesel deal, Saudi Yemen attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
Tweet
Share
E-mailGet Alerts GILD Hot Sheet
Price: $147.92 -1.67%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.3%
EPS Growth %: -13.4%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.3%
EPS Growth %: -13.4%
Join SI Premium – FREE
Biotech stocks could see action today after Gilead Sciences (Nasdaq: GILD) to acquire Pharmasset (Nasdaq: VRUS) for $137/share.
Watch sector ETFs: iShares Nasdaq Biotechnology (NYSE: IBB), SPDR S&P Biotech (NYSE: XBI).
Watch sector ETFs: iShares Nasdaq Biotechnology (NYSE: IBB), SPDR S&P Biotech (NYSE: XBI).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MuddyWaters Research: short Edison International
- Wells Fargo Assumes Globant S.A. (GLOB) at Equal Weight
- DRW and Marex complete OTC swap on Canton using tokenized index
Create E-mail Alert Related Categories
ETFs, Rumors, Trader TalkRelated Entities
Standard & Poor'sSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
